Stockreport

Cartesian (RNAC) Up as FDA Grants RMAT Tag to Descartes-08 [Yahoo! Finance]

Cartesian Therapeutics, Inc.  (RNAC) 
PDF pipeline candidate, Descartes-08, for the treatment of myasthenia gravis (“MG”), an autoimmune disease associated with muscle weakness. Shares of the company were up 3.5 [Read more]